September 12, 2023
The publication of the crystal structure of 4-AcO-EPT fumarate fumaric acid also exemplifies CaaMTech’s pioneering tryptamine prodrug and SAR research
August 4, 2023
Dialkyl tryptamines have received widespread attention for their potential to treat numerous mood disorders. But secondary tryptamines, or monoalkyl tryptamines, have received almost no such attention.
March 28, 2023
4-Pro-DMT is a synthetic psilocybin analog and purported prodrug of psilocin
March 14, 2023
4-HO-NiPT is an active metabolite of 4-HO-DiPT and closely related to norpsilocin
November 15, 2022
Researchers directly compared psilocybin with understudied magic mushroom molecules, and synthetic analogs such as psilacetin
September 22, 2022
4-HO-DiPT has been proposed as a more clinically-optimized alternative to psilocybin
September 14, 2022
Aeruginascin is a naturally-occurring quaternary tryptammonium compound found in Magic Mushrooms
July 6, 2022
CaaMTech will help carry on Dr. Alexander Shulgin’s legacy by developing ASRI’s novel compounds
June 15, 2022
O’Shaughnessy brings decades of experience in intellectual property strategy, collaborations, and development within the life sciences and pharmaceutical industries
June 2, 2022
A new paper published by The Leibniz Institute for Natural Product Research in collaboration with CaaMTech reveals the complex chemistry of magic mushrooms
